Lilly

NVIDIA announced the BioNeMo Agent Toolkit, a suite of domain-specific tools and skills for AI agents in life sciences, enabling faster scientific discovery. More than 50 companies, including Dassault…

Eli Lilly reported positive interim Phase 1b data for its in vivo PCSK9 base editor VERVE-102, showing single-dose LDL-C reductions of up to 62% sustained for 18 months in patients with heterozygous f…

NVIDIA CEO Jensen Huang told Dell Technologies World attendees Monday that demand for AI is "going parabolic, utterly parabolic," as the industry shifts from pilot programs to large-scale agentic AI a…